ResMed Historical Balance Sheet

RMD Stock

USD 219.70 1.41 0.64%

Trend analysis of ResMed Inc balance sheet accounts such as Total Stockholder Equity of 5.9 B, Property Plant And Equipment Net of 844.2 M, Net Debt of 767.5 M or Retained Earnings of 6 B provides information on ResMed's total assets, liabilities, and equity, which is the actual value of ResMed Inc to its prevalent stockholders. By breaking down trends over time using ResMed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining ResMed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ResMed Inc is a good buy for the upcoming year.

ResMed Inventory

992.87 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About ResMed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ResMed Inc at a specified time, usually calculated after every quarter, six months, or one year. ResMed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ResMed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ResMed currently owns. An asset can also be divided into two categories, current and non-current.

ResMed Balance Sheet Chart

At present, ResMed's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 425.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 147.7 M.

Short Long Term Debt Total Other Current Liab Total Current Liabilities Retained Earnings Accounts Payable

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on ResMed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ResMed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Accounts Payable

An accounting item on the balance sheet that represents ResMed obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of ResMed Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from ResMed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.6B	873.9M	1.0B	1.1B
Total Assets	6.8B	6.9B	7.9B	8.3B

Short Long Term Debt Total Total Assets

ResMed balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant And Equipment Gross	Common Stock Total Equity	Short Term Investments
Total Assets		0.67	0.65	0.92	0.98	0.94	0.73	0.99	0.96	-0.36	0.99	0.43	-0.36	0.98	0.59	0.79	0.96	0.95	0.67	0.91	0.91	-0.12	0.91	0.89	0.42	0.72
Short Long Term Debt Total	0.67		0.35	0.57	0.52	0.54	0.84	0.58	0.53	-0.17	0.69	0.51	-0.17	0.58	0.45	0.95	0.61	0.48	0.22	0.89	0.56	0.16	0.83	0.35	0.42	0.55
Other Current Liab	0.65	0.35		0.79	0.6	0.65	0.56	0.6	0.6	-0.47	0.69	0.58	-0.47	0.65	0.43	0.5	0.57	0.54	0.48	0.66	0.45	-0.32	0.68	0.49	0.35	0.63
Total Current Liabilities	0.92	0.57	0.79		0.9	0.89	0.64	0.91	0.9	-0.32	0.92	0.4	-0.32	0.92	0.6	0.65	0.84	0.85	0.58	0.85	0.83	0.05	0.85	0.83	0.45	0.63
Total Stockholder Equity	0.98	0.52	0.6	0.9		0.95	0.59	0.99	0.98	-0.32	0.95	0.32	-0.32	0.98	0.57	0.66	0.96	0.98	0.71	0.81	0.94	-0.14	0.82	0.95	0.38	0.66
Property Plant And Equipment Net	0.94	0.54	0.65	0.89	0.95		0.5	0.94	0.92	-0.12	0.89	0.35	-0.12	0.94	0.75	0.64	0.9	0.91	0.61	0.8	0.96	-0.08	0.76	0.88	0.57	0.56
Net Debt	0.73	0.84	0.56	0.64	0.59	0.5		0.64	0.6	-0.66	0.8	0.66	-0.66	0.63	0.19	0.93	0.72	0.59	0.49	0.9	0.44	-0.19	0.92	0.42	0.15	0.82
Retained Earnings	0.99	0.58	0.6	0.91	0.99	0.94	0.64		0.99	-0.34	0.96	0.36	-0.33	0.99	0.59	0.7	0.95	0.97	0.65	0.85	0.93	-0.1	0.85	0.93	0.4	0.65
Accounts Payable	0.96	0.53	0.6	0.9	0.98	0.92	0.6	0.99		-0.33	0.95	0.25	-0.33	0.98	0.55	0.66	0.91	0.94	0.62	0.81	0.9	-0.13	0.83	0.96	0.36	0.65
Cash	-0.36	-0.17	-0.47	-0.32	-0.32	-0.12	-0.66	-0.34	-0.33		-0.49	-0.51	1.0	-0.32	0.32	-0.38	-0.44	-0.38	-0.55	-0.39	0.0	0.56	-0.52	-0.24	0.34	-0.73
Non Current Assets Total	0.99	0.69	0.69	0.92	0.95	0.89	0.8	0.96	0.95	-0.49		0.48	-0.49	0.96	0.5	0.82	0.95	0.92	0.68	0.93	0.84	-0.19	0.95	0.86	0.35	0.78
Non Currrent Assets Other	0.43	0.51	0.58	0.4	0.32	0.35	0.66	0.36	0.25	-0.51	0.48		-0.51	0.38	0.31	0.62	0.47	0.32	0.26	0.59	0.23	-0.28	0.56	0.04	0.38	0.49
Cash And Short Term Investments	-0.36	-0.17	-0.47	-0.32	-0.32	-0.12	-0.66	-0.33	-0.33	1.0	-0.49	-0.51		-0.32	0.32	-0.38	-0.44	-0.38	-0.55	-0.39	0.01	0.56	-0.52	-0.24	0.34	-0.73
Net Receivables	0.98	0.58	0.65	0.92	0.98	0.94	0.63	0.99	0.98	-0.32	0.96	0.38	-0.32		0.64	0.7	0.92	0.93	0.6	0.85	0.91	-0.11	0.86	0.92	0.46	0.62
Common Stock Shares Outstanding	0.59	0.45	0.43	0.6	0.57	0.75	0.19	0.59	0.55	0.32	0.5	0.31	0.32	0.64		0.44	0.47	0.46	0.06	0.55	0.73	0.16	0.46	0.49	0.94	0.09
Non Current Liabilities Total	0.79	0.95	0.5	0.65	0.66	0.64	0.93	0.7	0.66	-0.38	0.82	0.62	-0.38	0.7	0.44		0.74	0.62	0.4	0.96	0.62	-0.12	0.93	0.48	0.39	0.71
Inventory	0.96	0.61	0.57	0.84	0.96	0.9	0.72	0.95	0.91	-0.44	0.95	0.47	-0.44	0.92	0.47	0.74		0.98	0.77	0.85	0.88	-0.19	0.84	0.84	0.31	0.76
Other Current Assets	0.95	0.48	0.54	0.85	0.98	0.91	0.59	0.97	0.94	-0.38	0.92	0.32	-0.38	0.93	0.46	0.62	0.98		0.78	0.76	0.91	-0.17	0.77	0.92	0.27	0.7
Other Stockholder Equity	0.67	0.22	0.48	0.58	0.71	0.61	0.49	0.65	0.62	-0.55	0.68	0.26	-0.55	0.6	0.06	0.4	0.77	0.78		0.51	0.56	-0.39	0.55	0.65	-0.07	0.78
Total Liab	0.91	0.89	0.66	0.85	0.81	0.8	0.9	0.85	0.81	-0.39	0.93	0.59	-0.39	0.85	0.55	0.96	0.85	0.76	0.51		0.75	-0.07	0.98	0.66	0.45	0.74
Total Current Assets	0.91	0.56	0.45	0.83	0.94	0.96	0.44	0.93	0.9	0.0	0.84	0.23	0.01	0.91	0.73	0.62	0.88	0.91	0.56	0.75		0.07	0.7	0.88	0.55	0.46
Short Term Debt	-0.12	0.16	-0.32	0.05	-0.14	-0.08	-0.19	-0.1	-0.13	0.56	-0.19	-0.28	0.56	-0.11	0.16	-0.12	-0.19	-0.17	-0.39	-0.07	0.07		-0.16	-0.09	0.19	-0.43
Intangible Assets	0.91	0.83	0.68	0.85	0.82	0.76	0.92	0.85	0.83	-0.52	0.95	0.56	-0.52	0.86	0.46	0.93	0.84	0.77	0.55	0.98	0.7	-0.16		0.69	0.35	0.8
Property Plant And Equipment Gross	0.89	0.35	0.49	0.83	0.95	0.88	0.42	0.93	0.96	-0.24	0.86	0.04	-0.24	0.92	0.49	0.48	0.84	0.92	0.65	0.66	0.88	-0.09	0.69		0.27	0.53
Common Stock Total Equity	0.42	0.42	0.35	0.45	0.38	0.57	0.15	0.4	0.36	0.34	0.35	0.38	0.34	0.46	0.94	0.39	0.31	0.27	-0.07	0.45	0.55	0.19	0.35	0.27		0.06
Short Term Investments	0.72	0.55	0.63	0.63	0.66	0.56	0.82	0.65	0.65	-0.73	0.78	0.49	-0.73	0.62	0.09	0.71	0.76	0.7	0.78	0.74	0.46	-0.43	0.8	0.53	0.06

Click cells to compare fundamentals

ResMed Account Relationship Matchups

ResMed balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	4.7B	5.1B	6.8B	6.9B	7.9B	8.3B
Short Long Term Debt Total	793.7M	917.6M	1.6B	873.9M	1.0B	1.1B
Other Current Liab	749.2M	322.9M	343.7M	352.4M	405.3M	425.5M
Total Current Liabilities	911.8M	689.3M	758.5M	910.7M	1.0B	1.1B
Total Stockholder Equity	2.9B	3.4B	4.1B	4.9B	5.6B	5.9B
Property Plant And Equipment Net	592.1M	630.5M	665.8M	699.1M	804.0M	844.2M
Net Debt	498.4M	643.8M	1.4B	635.6M	730.9M	767.5M
Retained Earnings	3.1B	3.6B	4.3B	5.0B	5.7B	6.0B
Accounts Payable	138.0M	159.2M	150.8M	237.7M	273.4M	287.1M
Cash	295.3M	273.7M	227.9M	238.4M	274.1M	333.5M
Non Current Assets Total	3.2B	3.2B	4.4B	4.5B	5.2B	5.5B
Non Currrent Assets Other	240.8M	251.5M	395.4M	114.2M	131.4M	73.7M
Cash And Short Term Investments	295.3M	273.7M	227.9M	238.4M	274.1M	338.0M
Net Receivables	614.3M	576.0M	704.9M	837.3M	962.9M	1.0B
Common Stock Shares Outstanding	146.5M	147.0M	147.5M	147.6M	169.7M	147.7M
Liabilities And Stockholders Equity	4.7B	5.1B	6.8B	6.9B	7.9B	8.3B
Non Current Liabilities Total	930.7M	1.0B	1.9B	1.1B	1.3B	1.3B
Inventory	457.0M	743.9M	998.0M	822.3M	945.6M	992.9M
Other Current Assets	208.2M	337.9M	437.0M	459.8M	528.8M	555.2M
Other Stockholder Equity	(1.1M)	59.2M	148.8M	123.3M	111.0M	116.6M
Total Liab	1.8B	1.7B	2.6B	2.0B	2.3B	2.4B
Total Current Assets	1.6B	1.9B	2.4B	2.4B	2.7B	2.8B
Short Term Debt	35.6M	53.6M	53.7M	60.5M	69.5M	68.6M
Intangible Assets	392.6M	345.9M	552.3M	485.9M	558.8M	586.7M
Property Plant And Equipment Gross	592.1M	630.5M	665.8M	1.4B	1.6B	1.7B
Accumulated Other Comprehensive Income	(193.5M)	(312.7M)	(272.5M)	(251.5M)	(226.4M)	(215.1M)
Common Stock	580K	583K	586K	588K	676.2K	443.7K
Other Assets	145.6M	240.8M	202.3M	261.3M	300.5M	315.5M
Good Will	1.9B	1.9B	2.8B	2.8B	3.3B	3.4B
Property Plant Equipment	535.7M	592.1M	630.5M	665.8M	765.7M	384.1M
Other Liab	221.6M	172.6M	160.0M	315.2M	362.5M	380.6M
Long Term Debt	643.4M	765.3M	1.4B	697.3M	801.9M	482.4M
Current Deferred Revenue	109.6M	108.7M	138.1M	152.6M	175.4M	184.2M
Net Tangible Assets	158.5M	565.2M	1.1B	807.3M	726.5M	632.7M
Long Term Debt Total	1.3B	1.2B	643.4M	765.3M	880.1M	737.7M
Capital Surpluse	1.5B	1.6B	1.6B	1.7B	1.9B	1.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:

How To Invest In ResMed

Details

Is ResMed Stock a good investment?

Details

What is ResMed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.649

Dividend Share

2.02

Earnings Share

8.41

Revenue Per Share

33.541

Quarterly Revenue Growth

0.103

The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ResMed Historical Balance Sheet

ResMed Inventory

992.87 Million

About ResMed Balance Sheet Analysis

ResMed Balance Sheet Chart

Total Current Liabilities

Retained Earnings

Accounts Payable

ResMed balance sheet Correlations

ResMed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ResMed balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Retained Earnings	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Accounts Payable	+ 0.99	Retained Earnings
Net Receivables	+ 0.99	Retained Earnings

Short Term Investments	- 0.73	Cash And Short Term Investments
Short Term Investments	- 0.73	Cash
Cash And Short Term Investments	- 0.66	Net Debt
Cash	- 0.66	Net Debt
Other Stockholder Equity	- 0.55	Cash And Short Term Investments
Other Stockholder Equity	- 0.55	Cash